A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
60 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the First Affiliated Hispital of Bengbu Medical University
Bengbu, Anhui, China
Recruiting - Anhui Provincial Cancer Hospital
Hefei, Anhui, China
Recruiting - the First Affiliated Hispital of Anhui Medical University
Hefei, Anhui, China
Recruiting - Maanshan People'S Hospital
Maanshan, Anhui, China
Recruiting - Beijing Cancer Hospital
Beijing, Beijing Municipality, China
Recruiting - the First Medical Center of Pla Ggeneral Hospital
Beijing, Beijing Municipality, China
Recruiting - the First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
Recruiting - the Second Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
Recruiting - Fujian Cancer Hospital
Fuzhou, Fujian, China
Recruiting - Fujian Provincial Hospital
Fuzhou, Fujian, China
Recruiting - the Second Affiliated Hospital of Fujian Medical University
Quanzhou, Fujian, China
Not, yet, recruiting - Gansu Provincial Cancer Hospital
Lanzhou, Gansu, China
Recruiting - Guangdong Maternal and Child Health Hospital
Guangzhou, Guangdong, China
Recruiting - Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Guangzhou, Guangdong, China
Recruiting - Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong, China
Recruiting - Zhongshan City People'S Hospital
Zhongshan, Guangdong, China
Recruiting - Guangxi Medical University Cancer Hospital
Nanning, Guangxi, China
Recruiting - First Hospital of Qinhuangdao
Qinhuangdao, Hebei, China
Recruiting - the Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
Recruiting - Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, China
Recruiting - Anyang Tumor Hospital
Anyang, Henan, China
Recruiting - the First Affiliated Hospital of Henan University of Science & Technology
Luoyang, Henan, China
Recruiting - the Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital
Zhengzhou, Henan, China
Recruiting - the First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
Recruiting - Hubei Cancer Hospital
Wuhan, Hubei, China
Recruiting - Wuhan Central Hospital
Wuhan, Hubei, China
Recruiting - Wuhan University Zhongnan Hospital
Wuhan, Hubei, China
Not, yet, recruiting - Xiangyang Central Hospital
Xiangyang, Hubei, China
Recruiting - the First People'S Hospital of Changde City
Changde, Hunan, China
Recruiting - Hunan Cancer Hospital
Changsha, Hunan, China
Recruiting - Xiangya Hospital of Central South University
Changsha, Hunan, China
Recruiting - the Central Hospital of Yongzhou
Yongzhou, Hunan, China
Recruiting - Jiangsu Cancer Hospital
Nanjing, Jiangsu, China
Recruiting - Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China
Recruiting - the First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China
Recruiting - Xuzhou Central Hospital
Xuzhou, Jiangsu, China
Recruiting - Jiangxi Cancer Hospital
Nanchang, Jiangxi, China
Recruiting - Jilin Cancer Hospital
Changchun, Jilin, China
Recruiting - the First Hospital of Jilin University
Changchun, Jilin, China
Recruiting - the Second Hospital of Dalian Medical University
Dalian, Liaoning, China
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Nov 2024
- Primary completion
- 31 Aug 2028
- Completion
- 31 Aug 2028
- Last update posted
- 22 Sept 2025
- Registered enrollment
- 460
- Registry id
- NCT06680921
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.